136 related articles for article (PubMed ID: 36597712)
1. Pediatric growth hormone and prolactin-secreting tumor associated with an
Alexandre MI; Faria CC; Gomes A; Bugalho MJ
J Pediatr Endocrinol Metab; 2023 Feb; 36(2):199-202. PubMed ID: 36597712
[TBL] [Abstract][Full Text] [Related]
2. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.
Stratakis CA; Tichomirowa MA; Boikos S; Azevedo MF; Lodish M; Martari M; Verma S; Daly AF; Raygada M; Keil MF; Papademetriou J; Drori-Herishanu L; Horvath A; Tsang KM; Nesterova M; Franklin S; Vanbellinghen JF; Bours V; Salvatori R; Beckers A
Clin Genet; 2010 Nov; 78(5):457-63. PubMed ID: 20507346
[TBL] [Abstract][Full Text] [Related]
3. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature.
Gummadavelli A; Dinauer C; McGuone D; Vining EM; Erson-Omay EZ; Omay SB
J Clin Neurosci; 2020 Aug; 78():420-422. PubMed ID: 32336638
[TBL] [Abstract][Full Text] [Related]
4. Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients.
Yarman S; Tuncer FN; Serbest E
Pathobiology; 2019; 86(2-3):128-134. PubMed ID: 30630164
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
[TBL] [Abstract][Full Text] [Related]
6. A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.
Urbani C; Russo D; Raggi F; Lombardi M; Sardella C; Scattina I; Lupi I; Manetti L; Tomisti L; Marcocci C; Martino E; Bogazzi F
J Endocrinol Invest; 2014 Oct; 37(10):949-55. PubMed ID: 24996936
[TBL] [Abstract][Full Text] [Related]
7. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
[TBL] [Abstract][Full Text] [Related]
8. Co-occurrence of
DE Melo FM; Bastos-Rodrigues L; Sarquis MM; Friedman E; DE Marco L
Anticancer Res; 2018 Jun; 38(6):3683-3687. PubMed ID: 29848728
[TBL] [Abstract][Full Text] [Related]
9. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
Iacovazzo D; Caswell R; Bunce B; Jose S; Yuan B; Hernández-Ramírez LC; Kapur S; Caimari F; Evanson J; Ferraù F; Dang MN; Gabrovska P; Larkin SJ; Ansorge O; Rodd C; Vance ML; Ramírez-Renteria C; Mercado M; Goldstone AP; Buchfelder M; Burren CP; Gurlek A; Dutta P; Choong CS; Cheetham T; Trivellin G; Stratakis CA; Lopes MB; Grossman AB; Trouillas J; Lupski JR; Ellard S; Sampson JR; Roncaroli F; Korbonits M
Acta Neuropathol Commun; 2016 Jun; 4(1):56. PubMed ID: 27245663
[TBL] [Abstract][Full Text] [Related]
10. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
[TBL] [Abstract][Full Text] [Related]
11. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
12. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.
Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J
Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526
[TBL] [Abstract][Full Text] [Related]
13. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
[TBL] [Abstract][Full Text] [Related]
14. AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.
Ramírez-Rentería C; Hernández-Ramírez LC; Portocarrero-Ortiz L; Vargas G; Melgar V; Espinosa E; Espinosa-de-Los-Monteros AL; Sosa E; González B; Zúñiga S; Unterländer M; Burger J; Stals K; Bussell AM; Ellard S; Dang M; Iacovazzo D; Kapur S; Gabrovska P; Radian S; Roncaroli F; Korbonits M; Mercado M
Endocrine; 2016 Aug; 53(2):402-11. PubMed ID: 27033541
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening.
Mangupli R; Rostomyan L; Castermans E; Caberg JH; Camperos P; Krivoy J; Cuauro E; Bours V; Daly AF; Beckers A
Pituitary; 2016 Oct; 19(5):507-14. PubMed ID: 27287035
[TBL] [Abstract][Full Text] [Related]
16. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
Stratakis CA; Schussheim DH; Freedman SM; Keil MF; Pack SD; Agarwal SK; Skarulis MC; Weil RJ; Lubensky IA; Zhuang Z; Oldfield EH; Marx SJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4776-80. PubMed ID: 11134142
[TBL] [Abstract][Full Text] [Related]
17. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
18. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Beckers A; Aaltonen LA; Daly AF; Karhu A
Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
[TBL] [Abstract][Full Text] [Related]
19. Genetics of pituitary adenomas.
Gadelha MR; Trivellin G; Hernández Ramírez LC; Korbonits M
Front Horm Res; 2013; 41():111-40. PubMed ID: 23652674
[TBL] [Abstract][Full Text] [Related]
20. Novel Germline c.105_107dupGCT
Stasiak M; Dedecjus M; Zawadzka-Starczewska K; Adamska E; Tomaszewska M; Lewiński A
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32847108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
